Nlem

There are around 800 drugs on the National List of Essential Medicines maintained by the Department of Pharmaceuticals. The pricing is arrived at by the National Pharmaceutical Pricing Authority on the basis of the WPI of the previous calendar year.

Govt caps trade margins of 42 cancer drugs

Currently, 57 anti-cancer drugs are under price control as scheduled formulations.

Indian drug market growth moderates to 7.1% in February

The domestic drug market grew at 7.1 percent in February compared to 13.5 percent growth in the same period last year, according to data from market research firm AIOCD-AWACS.

Alkem Labs Q2 net inches up 6% to Rs 283 cr

Drug firm Alkem Laboratories today reported a 5.96 per cent rise in its consolidated net profit to Rs 282.83 crore for the quarter to September, mainly on back of robust sales.

Cut target on GSK Pharma, see gradual recovery: Credit Suisse

With maintaining neutral rating on Glaxosmithkline Pharmaceutical, Credit Suisse slashed target price to Rs 2,850 as it continues to struggle with price control & supply constraints in some products. It also reduced FY17 earnings per share by 41 percent.

Torrent Pharma Q1 net may fall 23%, rev seen down; US biz key

Steeper-than-anticipated decline in revenue and US business will be considered weak despite high base. Margin decline below 30 percent will be taken as a disappointment. India growing less than 10 percent will be considered subdued.

Good demand from anchor investors for IPO: Alkem Labs

Alkem is looking to raise around Rs 1300 crore through its IPO by offering 1.28 crore shares in a price band of Rs 1020-1050. The entire issue is an offer for sale by existing shareholders.

Government clears Mylan's takeover of Jai Pharma

With this approval, FDI of USD 750 million will be received in the country, it added. The approval has been accorded subject to certain conditions.

See Q2 better than Q1; US biz growth in 25-30% range: Lupin

According to Kamal Sharma, Lupin should perform better in Q2 than Q1 and eyes double digit growth as against virtually no growth in Q1.

NPPA to fix cap on prices of over 300 drugs by month-end

Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) said that it will fix the ceiling prices of over 300 formulation-based drugs by the month-end.

Pricing mechanism to impact earnings of Pharma cos: ICRA

A market-based pricing mechanism is more acceptable to pharma industry and over a longer-period may limit the adverse impact on the industry, says ICRA.

New pricing norms may hit pharma cos' earnings: ICRA

With the National List of Essential Medicines (NLEM) estimated to cover almost 20 percent of the Rs 72,800 crore domestic formulation business, an expected price cut of 15-20 percent will erode the market by 3-4 percent, the ICRA report said.

Life saving drugs prices set to fall soon

According to the approved policy, prices of medicines will now be capped by taking simple average of all brands which have more than one per cent market share instead of input costs.

Pharma GoM agrees to limted price control on NLEM

CNBC-TV18's Archana Shukla, quoting sources, reports that in a high profile meeting held on Thursday, the GoM has agreed to limit price control only to the National List Of Essential Medicines